Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ascletis completes $100m Series B Financing
Ascletis, a biotechnology company engaged in the discovery, development and commercialization of new treatments for liver diseases, has raised $100m in series B financing.
Drug Discovery
-
04 Jan 2017
-
03 Jan 2017
Factor One Source Pharmacy to buy Fast Access Specialty Therapeutics
Factor One Source Pharmacy (FOSRx) has agreed to acquire Fast Access Specialty Therapeutics (F.A.S.T.) for a combination of cash and stock.
-
02 Jan 2017
TetraLogic sells SMAC Mimetic and HDAC Inhibitor assets to Medivir
TetraLogic Pharmaceuticals has completed the sale of its SMAC Mimetic and HDAC Inhibitor assets to Medivir.
-
07 Nov 2016
Onxeo unveils encouraging results from preclinical studies of Livatag in pancreatic cancer
Biopharmaceutical firm Onxeo has announced encouraging results from a series of preclinical studies evaluating Livatag interest for pancreatic cancer.